Emerging avenues in immunotherapy for the management of malignant pleural mesothelioma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2466
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Emerging avenues in immunotherapy for the management of malignant pleural mesothelioma ; volume:21 ; number:1 ; day:5 ; month:5 ; year:2021 ; pages:1-24 ; date:12.2021
BMC pulmonary medicine ; 21, Heft 1 (5.5.2021), 1-24, 12.2021
- Creator
-
Gray, Steven G.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12890-021-01513-7
- URN
-
urn:nbn:de:101:1-2021090819503263115304
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:29 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Gray, Steven G.
- SpringerLink (Online service)
Other Objects (12)
Assessment of new HDAC inhibitors for immunotherapy of malignant pleural mesothelioma
ADAM10 mediates malignant pleural mesothelioma invasiveness
Early detection of malignant pleural mesothelioma
KRAS signaling in malignant pleural mesothelioma
Molecular biological analysis of malignant pleural mesothelioma
Therapeutic potential of targeting S100A11 in malignant pleural mesothelioma
Synthetic lethality in malignant pleural mesothelioma with PARP1 inhibition
GAS5 long non-coding RNA in malignant pleural mesothelioma
Exceptional Regression of Malignant Pleural Mesothelioma with Pembrolizumab Monotherapy
Metabolic rewiring and redox alterations in malignant pleural mesothelioma
Correlation between pleural fluid cytology and magnitude of pleural invasion in patients with malignant pleural mesothelioma
Physician requests by patients with malignant pleural mesothelioma in Japan
Assessment of new HDAC inhibitors for immunotherapy of malignant pleural mesothelioma
ADAM10 mediates malignant pleural mesothelioma invasiveness
Early detection of malignant pleural mesothelioma
KRAS signaling in malignant pleural mesothelioma
Molecular biological analysis of malignant pleural mesothelioma
Therapeutic potential of targeting S100A11 in malignant pleural mesothelioma
Synthetic lethality in malignant pleural mesothelioma with PARP1 inhibition
GAS5 long non-coding RNA in malignant pleural mesothelioma
Exceptional Regression of Malignant Pleural Mesothelioma with Pembrolizumab Monotherapy
Metabolic rewiring and redox alterations in malignant pleural mesothelioma
Correlation between pleural fluid cytology and magnitude of pleural invasion in patients with malignant pleural mesothelioma
Physician requests by patients with malignant pleural mesothelioma in Japan
Assessment of new HDAC inhibitors for immunotherapy of malignant pleural mesothelioma
ADAM10 mediates malignant pleural mesothelioma invasiveness
Early detection of malignant pleural mesothelioma
KRAS signaling in malignant pleural mesothelioma
Molecular biological analysis of malignant pleural mesothelioma
Therapeutic potential of targeting S100A11 in malignant pleural mesothelioma
Synthetic lethality in malignant pleural mesothelioma with PARP1 inhibition
GAS5 long non-coding RNA in malignant pleural mesothelioma
Exceptional Regression of Malignant Pleural Mesothelioma with Pembrolizumab Monotherapy
Metabolic rewiring and redox alterations in malignant pleural mesothelioma
Correlation between pleural fluid cytology and magnitude of pleural invasion in patients with malignant pleural mesothelioma